Stablepoint Partners, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2011237 BRAINTREE, MA

Position in GILD

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$2,911,757

-$324,553 QoQ

Shares Held

23,047

-0.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.51%

of 13F equity value

Holder Rank

#722

of 2,266 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Stablepoint Partners, LLC holds $55,827,894 across 12 Drug Manufacturers - General names. GILD ranks #8 (5.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	31,144	$11,277,865
2	MRK	Merck & Co., Inc.	67,206	$8,635,971
3	JNJ	Johnson & Johnson	29,950	$7,606,401
4	GSK	GSK plc	109,711	$5,751,050
5	ABBV	AbbVie Inc.	21,670	$5,453,038
6	PFE	Pfizer Inc	201,036	$4,840,946
7	LLY	ELI LILLY & Co	3,240	$3,886,153
8	GILD	Gilead Sciences, Inc. This page	23,047	$2,911,757

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,911,757	23,047	-0.7%	Shares	Sole	2026-07-09
2026-03-31	$3,236,310	23,221	-7.0%	Shares	Sole	2026-04-30
2025-12-31	$3,064,695	24,969	+1.4%	Shares	Sole	2026-01-13
2025-09-30	$2,734,041	24,631	-4.8%	Shares	Sole	2025-11-03
2025-06-30	$2,867,541	25,864	-3.6%	Shares	Sole	2025-08-13
2025-03-31	$3,005,405	26,822	-5.0%	Shares	Sole	2025-04-11
2024-12-31	$2,607,143	28,225	+1.4%	Shares	Sole	2025-01-21
2024-09-30	$2,334,776	27,848	+1.8%	Shares	Sole	2024-10-11
2024-06-30	$1,877,649	27,367	+13.2%	Shares	Sole	2024-08-02
2024-03-31	$1,770,159	24,166	+31.1%	Shares	Sole	2024-04-23
2023-12-31	$1,493,500	18,436	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.